Assessment of vascular disease using arterial flow mediated dilatation.
Journal Title: Pharmacological Reports - Year 2006, Vol 58, Issue 0
Abstract
Arterial endothelial dysfunction occurs at all stages of atherosclerosis, both preceding structural atherosclerosis changes, as well as predisposing to clinical events in late obstructive disease. Endothelial dysfunction is thus well correlated with risks of vascular events. Release of endothelial nitric oxide has been shown to be a key player in normal endothelial function. Endothelial function can be measured in the coronary arteries and peripheral vascular tree by intra-arterial infusion of substances that promote release of nitric oxide, but this method is limited by its invasive nature which limits its widespread use in asymptomatic subjects. Flow mediated dilatation is a non invasive ultrasound-based method where arterial diameter is measured in response to an increase in shear stress, which causes release of nitric oxide from the endothelium and consequent endothelium dependent dilatation. Flow mediated dilatation has been shown to correlate with invasive measures of endothelial function, as well as with the presence and severity of the major traditional vascular risk factors. This noninvasive endothelial function testing has also demonstrated the potential reversibility of endothelial dysfunction by various strategies including cessation of smoking, weight loss in obese subjects, certain pharmacological agents (statins, ACE inhibitors), L-arginine and hormones.
Authors and Affiliations
Sanjay Patel, David Celermajer
Gap junctions synchronize vascular tone within the microcirculation.
Gap junctions are formed in the cardiovascular system by connexin40 (Cx40), Cx37, Cx43, and Cx45. These low resistance channels allow the transfer of ions and small molecules between cells. The longitudinal coupling of e...
Modulation of chemical signaling: current problems after four decades of research. Symposium on the occasion of the retirement of Professor Manfred Göthert. Bonn [Germany], June 10, 2006.
Involvement of adenosine receptor agonists on the development of hypersensitivity to acute dose of morphine during morphine withdrawal period.
In the present study, the involvement of the selective adenosine A(1) (CPA) and A(2A) (CGS 21680) and non-selective adenosine A(1)/A(2A) (NECA) receptor agonists on the development of hypersensitivity to acute morphine i...
Effects of acute and chronic treatment with magnesium in the forced swim test in rats.
The antidepressant-like activity of magnesium, the non-specific N-methyl-D-aspartate glutamate receptor antagonist, in the mice forced swim test was demonstrated previously. In the present study, the effects of this biom...
A carbon monoxide-releasing molecule (CORM-3) attenuates lipopolysaccharide- and interferon-gamma-induced inflammation in microglia.
The development of carbon monoxide-releasing molecules (CO-RMs) in recent years helped to shed more light on the diverse range of anti-inflammatory and cytoprotective activities of CO gas. In this study, we examined the...